Clinical Trial Update: Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing everolimus versus mycophenolate mofetil, both with reduced-dose cyclosporine microemulsion, as maintenance therapy in heart transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• Everolimus (everolimus)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Transplantation | Phase 4 | Status: COMPLETED